Start by working backward from Scleritodermin A to identify key fragments and disconnections. The C?-N?? fragment should be one of these key pieces.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
BOC-DL-ILE-OH
2-(3-isopropyl-4-methoxyphenethyl)-3-methylcyclohex-2-en-1-one
[2aS,3R,6R(1S,2R),7aS,7bR]-hexahydro-2,2-bis(1-methylethyl)-3-ethenyl-6-[(2-phenylcyclohexyl)oxy]-2H-1,4,5-trioxy-4a-aza-2-silacyclopent[cd]indene
3-ethoxy-N-(p-ethoxy-phenethyl) phthalimide
(E,E,7S)-8-<(2R,6S)-6-<(2S,3R,4S,6R,7R,8R,9S,10S,11S)-2-methoxy-3,7,9,11-tetramethyl-8,10-dihydroxy-4,6-((R)-para-methoxybenzylidenedioxy)-13-((2S,4R,6S)-2-methyl-4-methoxytetrahydropyran-6-yl)-tridecan-1-yl>-5,6-dihydro-2H-pyran-2-yl>-7-tert-butyldi...
1-({[(1S,2S)-2-ethenylcyclopropyl]methoxy}methyl)-4-methoxybenzene
C46H62N6O9S3Si2
dibenzyl (E)-1-propenylphosphonate
ethyl 5-(benzyloxy)-2-(diethoxyphosphoryl)pentanoate
3-Pyridinol,4-methoxy-(9CI)
Nα-(benzyloxycarbonyl)-Nβ-(tert-butoxycarbonyl)-Nβ-methyl-L-α,β-diaminopropionic acid
3-(2-chloro-4-hydroxyphenylethynyl)-2-methylcyclohex-2-enone
phenylmethyl 2-trimethylsilylethynyl-1(2H)-pyridinecarboxylate
Silica gel
2H-Pyran-2-ol, 5,6-dihydro-3,5-dimethyl-6-[(1S)-1-methyl-2-(phenylmethoxy)ethyl]-, (5S,6R)-
C28H50O4Si2
daphneticin
(S)-tert-butyl 2-amino-3-(2-bromo-5-hydroxyphenyl)propanoate
tetra-N-benzyl-5,6-O-cyclohexylidene-tetra-N-methoxycarbonylneamin
N,N-diethyl-2-(tert-butyldimethylsilyloxy)-4-methylbenzamide
(R)-3-[(4R,6S)-6-(2-Benzyloxy-ethyl)-2,2-dimethyl-[1,3]dioxan-4-yl]-1-{(4R,6R)-6-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-2,2-dimethyl-[1,3]dioxan-4-yl}-propan-1-ol
2-Cyclohexen-1-one, 6-acetyl-2-methyl-5-(1-methylethenyl)-, (5S)-
(S,E)-1-(benzyloxy)hex-4-en-3-ol
Methyl (Z)-2-(phenylselanylcarbonylethyl)cyclohexylideneacetate
1-Propanone, 3-(3-aminophenyl)-1-(2-hydroxy-5-methoxyphenyl)-
(2S,3R,4S,5R)-5-(tert-Butyl-diphenyl-silanyloxymethyl)-2,3,4,5-tetrahydro-[2,3']bifuranyl-3,4-diol
2-(9-(Benzolsulfonyl)-13-<(benzolsulfonyl)amino>-5,9-diazatridecyl)-2-nitrocyclododecanon
6-[3-(tert-butyl-dimethyl-silanyloxy)-propyl]-3-methoxymethoxy-cyclohex-2-enone
methyl 2-(3,4-dimethoxyphenyl)hex-5-enoate
(S)-5-Hydroxymethyl-1-(2-nitro-benzoyl)-pyrrolidin-2-one
8-cyclopropyl-3-[2-(3-fluorophenyl)ethyl]-7,8-dihydro-3H-[1,3]oxazino[6,5-g][1,2,3]benzotriazine-4,9-dione
(1R,2S,3R)-1-(t-butyldiphenylsilyloxy)-1-phenylbutane-2,3,4-triol
tert-Butyl-{(R)-2-[(3aR,5R,6S,6aR)-5-((R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yloxy]-1-phenyl-buta-2,3-dienyloxy}-diphenyl-silane
C15H20O3
Benzenemethanol, 3-methoxy-4-(2-propenyloxy)-
(-)-6-O-benzyl-1-deoxy-1-(dimethylphosphono)-3,4-O-isopropylidene-D-ribo-hexofuranose
(4aR,6S,7S,8S,8aR)-6-allyl-8-(benzyloxy)-2,2-di-tert-butyl-7-methylhexahydropyrano[3,2-d][1,3,2]dioxasilin-7-ol
methyl phaseate
(1R,2S,4S,7R,SS)-(-)-bicyclo <2.2.1> hep-7-benzyloxymethyl-5-ene-2-p-toluenesulfinyl
(S)-(+)-2-methylpentyl p-nitrophenylsulfonate
(3aR,4R,5R,6aS)-5-(benzoyloxy)hexahydro-4-(iodomethyl)-2H-cyclopentafuran-2-one
(2Z,4E)-1-[(4-Methoxy-phenyl)-diphenyl-methoxy]-tetradeca-2,4-dien-8-yn-6-ol
Oxalyl chloride
MAGNESIUM SULFATE
3’-isopropyl-4’,5’-dimethoxyacetophenone
C16H18BrNO2
2-aza-4'-demethyldeoxypodophyllotoxin
MK-4827 (tosylate)
(R)-3-((S)-1-Methyl-cyclohex-2-enyl)-tetrahydro-pyran-2-one
(3R,4R)-3,4-dimethyl-3-(p-tolyl)cyclopentanone
